Literature DB >> 25394582

Effects of sumatriptan nasal spray (Imigran) on isolated rat's tracheal smooth muscle.

Li-Hsiang Cheng1, Pei-Chuan Wu, Shao-Cheng Liu, Feng-Shiang Chiu, Yueng-Hsiang Chu, Ying-Nan Chang, Hsing-Won Wang.   

Abstract

Sumatriptan (Imigran) is a potent and highly selective 5-HT1 receptor agonist often used in treating acute migraine. Intranasal sumatriptan is well absorbed and is generally effective in relieving headache. However, the effects of Imigran given intratracheally have rarely been well explored. We aimed to verify the effect of Imigran, which acts on the tracheal smooth muscle directly in vitro. We examined the effectiveness of Imigran on isolated rat tracheal smooth muscle by testing: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 10(-6) M methacholine as a parasympathetic mimetic; (3) effect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. The addition of Imigran at doses of 10(-5) M or above elicited a significant relaxation response to 10(-6) M methacholine-induced contraction. Imigran could inhibit electrical field stimulation-induced spike contraction. It also had a minimal effect on the basal tension of trachea as the concentration increased. The study indicated high concentrations of Imigran could cause bronchodilation to reduce asthma attacks not only by blocking parasympathetic tone, but also by directly antagonizing the effect of cholinergic receptors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394582     DOI: 10.1007/s00405-014-3392-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

Review 1.  Sumatriptan: pharmacological basis and clinical results.

Authors:  C G Dahlöf
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

2.  Open label study of intranasal sumatriptan (Imigran) for footballer's headache.

Authors:  P McCrory; J Heywood; A Ugoni
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

3.  Effects of prokinetic agents on contractile responses to electrical field stimulation of isolated guinea pig trachea.

Authors:  K I Yau; F N Ko; C H Chien
Journal:  J Formos Med Assoc       Date:  1999-08       Impact factor: 3.282

4.  Do cholinergic neurons directly innervate nasal blood vessels?

Authors:  H W Wang; R T Jackson
Journal:  Rhinology       Date:  1988-06       Impact factor: 3.681

5.  Effects of temperature on cholinergic contractility of rabbit airway muscle.

Authors:  D L Bratton; D T Tanaka; M M Grunstein
Journal:  J Appl Physiol (1985)       Date:  1987-11

6.  Effect of low temperature on tracheal smooth muscle contractile and relaxing responses evoked by electrical field stimulation.

Authors:  O González; G E Santacana
Journal:  P R Health Sci J       Date:  2001-09       Impact factor: 0.705

7.  The nonadrenergic noncholinergic system can modulate the effect of prokinetic agents on contractile response of isolated guinea-pig trachea segments to electrical field stimulation.

Authors:  Kuo-Inn Yau; Tsong-Long Hwang
Journal:  J Formos Med Assoc       Date:  2002-10       Impact factor: 3.282

Review 8.  Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.

Authors:  Petra M C Callenbach; Lise P M Pels; Paul G H Mulder; Wim H J P Linssen; Rob H J M Gooskens; Jan L van der Zwan; Oebele F Brouwer
Journal:  Eur J Paediatr Neurol       Date:  2007-04-10       Impact factor: 3.140

9.  Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.

Authors:  Kati Ahonen; Mirja L Hämäläinen; Heikki Rantala; Kalle Hoppu
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

10.  Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.

Authors:  Shankar Natarajan; J T Jabbour; Christopher J Webster; Mary S Richardson
Journal:  Headache       Date:  2004 Nov-Dec       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.